Novartis International Ag - Company Profile
TABLE OF CONTENTS
I. INTRODUCTION 1
II. COMPANY HISTORY 1
III. CHIEF EXECUTIVE OFFICER 2
IV. MAJOR PRODUCTS 3
V. MAJOR COMPETITORS 5
VI. SALES HISTORY 6
VII. MAJOR FACTORS AFFECTING INVESTMENT POTENTIAL 7
VIII. STOCK PRICE DATA AND INVESTMENT ANALYSIS 8
IX. CONCLUSIONS & RECOMMENDATIONS 10
EXECUTIVE SUMMARY
This company profile provides a preliminary investigation and analysis of Novartis International AG, a multinational pharmaceutical company based in Basel, Switzerland. Novartis is one of ten companies the Investment Board will consider for further in-depth research for a multimillion-dollar investment.
Novartis was created in 1996 from the merger of two Swiss-based chemical/life sciences giants; Ciba-Geigy and Sandoz Laboratories. Novartis is comprised of four business divisions: pharmaceuticals, vaccines and diagnostics, Sandoz Generics, and consumer health. Dr. Daniel Vasella is Chairman of Novartis since 1999, and is Chief Executive......
View the rest of this paper...
Approximate Word Count: 2759
Approximate Pages: 12 (250 words per double-spaced page)
Why should you join Frat Files?
- - It's safe, secure, and private.
- - Instant access to over 100,000 papers. New papers are added hourly.
- - Fast and reliable customer support.
Frat Files
Members
Information
© 2009 FratFiles.com.